Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor

Por Macfarlane, Robyn, Seal, Melanie, Speers, Caroline, Woods, Ryan, Masoudi, Hamad, Aparicio, Samuel, Chia, Stephen K.
Publicado em 2012

Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast Cancer

Por Hedden, Lindsay, O'Reilly, Susan, Lohrisch, Caroline, Chia, Stephen, Speers, Caroline, Kovacic, Laurel, Taylor, Suzanne, Peacock, Stuart
Publicado em 2012

Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer

Por Pritchard, Kathleen I., Chia, Stephen K., Simmons, Christine, McLeod, Deanna, Paterson, Alexander, Provencher, Louise, Rayson, Daniel
Publicado no Oncologist (2016)

The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities

Por Teckle Paulos, Peacock Stuart, McTaggart-Cowan Helen, van der Hoek Kim, Chia Stephen, Melosky Barb, Gelmon Karen
Publicado em 2011-11-01

The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities

Por Teckle, Paulos, Peacock, Stuart, McTaggart-Cowan, Helen, van der Hoek, Kim, Chia, Stephen, Melosky, Barb, Gelmon, Karen
Publicado em 2011

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D

Por Teckle, Paulos, McTaggart-Cowan, Helen, Van der Hoek, Kim, Chia, Stephen, Melosky, Barb, Gelmon, Karen, Peacock, Stuart
Publicado no Health Qual Life Outcomes (2013)

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG...

Por Addison, Christina L., Pond, Gregory R., Cochrane, Brandy, Zhao, Huijun, Chia, Stephen K., Levine, Mark N., Clemons, Mark
Publicado no J Bone Oncol (2015)

Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: a population-based cohort study

Por Davidson, Ashley, Chia, Stephen, Olson, Robert, Nichol, Alan, Speers, Caroline, Coldman, Andy J., Bajdik, Chris, Woods, Ryan, Tyldesley, Scott
Publicado em 2013

Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study

Por Schneeweiss, Andreas, Chia, Stephen, Hegg, Roberto, Tausch, Christoph, Deb, Rahul, Ratnayake, Jayantha, McNally, Virginia, Ross, Graham, Kiermaier, Astrid, Cortés, Javier
Publicado no Breast Cancer Res (2014)

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

Por Pataky, Reka, Armstrong, Linlea, Chia, Stephen, Coldman, Andrew J, Kim-Sing, Charmaine, McGillivray, Barbara, Scott, Jenna, Wilson, Christine M, Peacock, Stuart
Publicado em 2013

Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast

Por Wykoff, Charles C., Beasley, Nigel, Watson, Peter H., Campo, Leticia, Chia, Stephen K., English, Ruth, Pastorek, Jaromir, Sly, William S., Ratcliffe, Peter, Harris, Adrian L.
Publicado em 2001

A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium

Por Taylor, Sara K., Chia, Stephen, Dent, Susan, Clemons, Mark, Agulnik, Mark, Grenci, Pamela, Wang, Lisa, Oza, Amit M., Ivy, Percy, Pritchard, Kathleen I., Leighl, Natasha B.
Publicado em 2010

The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers

Por Weymann, Deirdre, Laskin, Janessa, Roscoe, Robyn, Schrader, Kasmintan A., Chia, Stephen, Yip, Stephen, Cheung, Winson Y., Gelmon, Karen A., Karsan, Aly, Renouf, Daniel J., Marra, Marco, Regier, Dean A.
Publicado no Mol Genet Genomic Med (2017)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

Por Cheang, Maggie C. U., Chia, Stephen K., Voduc, David, Gao, Dongxia, Leung, Samuel, Snider, Jacqueline, Watson, Mark, Davies, Sherri, Bernard, Philip S., Parker, Joel S., Perou, Charles M., Ellis, Matthew J., Nielsen, Torsten O.
Publicado em 2009

Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort

Por Chapman, Judith-Anne W, Nielsen, Torsten O, Ellis, Matthew J, Bernard, Phillip, Chia, Stephen, Gelmon, Karen A, Pritchard, Kathleen I, Maitre, Aurelie Le, Goss, Paul E, Leung, Samuel, Shepherd, Lois E, Bramwell, Vivien H C
Publicado em 2013

A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen

Por Chia, Stephen K., Bramwell, Vivien H., Tu, Dongsheng, Shepherd, Lois E., Jiang, Shan, Vickery, Tammi, Mardis, Elaine, Leung, Samuel, Ung, Karen, Pritchard, Kathleen I., Parker, Joel S., Bernard, Philip S., Perou, Charles M., Ellis, Matthew J., Nielsen, Torsten O.
Publicado em 2012

A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER...

Por Chia, Stephen K., Ellard, Susan L., Mates, Mihaela, Welch, Stephen, Mihalcioiu, Catalin, Miller, Wilson H., Gelmon, Karen, Lohrisch, Caroline, Kumar, Vikaash, Taylor, Sara, Hagerman, Linda, Goodwin, Rachel, Wang, Tao, Sakashita, Shingo, Tsao, Ming S., Eisenhauer, Elizabeth, Bradbury, Penelope
Publicado no Breast Cancer Res (2017)

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

Por Cheang, Maggie C.U., Voduc, K. David, Tu, Dongsheng, Jiang, Shan, Leung, Samuel, K. Chia, Stephen, Shepherd, Lois E., Levine, Mark N., Pritchard, Kathleen I., Davies, Sherri, Stijleman, Inge J., Davis, Carole, Ebbert, Mark T. W., Parker, Joel S., Ellis, Matthew J., Bernard, Philip S., Perou, Charles M., Nielsen, Torsten O.
Publicado em 2012

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blin...

Por Baselga, José, Im, Seock-Ah, Iwata, Hiroji, Cortés, Javier, De Laurentiis, Michele, Jiang, Zefei, Arteaga, Carlos L, Jonat, Walter, Clemons, Mark, Ito, Yoshinori, Awada, Ahmad, Chia, Stephen, Jagiello-Gruszfeld, Agnieszka, Pistilli, Barbara, Tseng, Ling-Ming, Hurvitz, Sara, Masuda, Norikazu, Takahashi, Masato, Vuylsteke, Peter, Hachemi, Soulef, Dharan, Bharani, Di Tomaso, Emmanuelle, Urban, Patrick, Massacesi, Cristian, Campone, Mario
Publicado no Lancet Oncol (2017)

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

Por Cheang, Maggie C.U., Martin, Miguel, Nielsen, Torsten O., Prat, Aleix, Voduc, David, Rodriguez-Lescure, Alvaro, Ruiz, Amparo, Chia, Stephen, Shepherd, Lois, Ruiz-Borrego, Manuel, Calvo, Lourdes, Alba, Emilio, Carrasco, Eva, Caballero, Rosalia, Tu, Dongsheng, Pritchard, Kathleen I., Levine, Mark N., Bramwell, Vivien H., Parker, Joel, Bernard, Philip S., Ellis, Matthew J., Perou, Charles M., Di Leo, Angelo, Carey, Lisa A.
Publicado no Oncologist (2015)